Frontiers Journal of Pharmaceutical Sciences & Clinical Trials (FJPSCT)

Impacts Of The Aging Process On The Eyesight And Its Treatment By Avastin

Keywords : Avastin; Macular Degeneration; Lucentis; Choroidal Blood Capillaries, Choroidal Neovascular Membrane

Doi Number : 10.4172/2155-6700.1000002

Abstract

The eye is one of the delicate organs that easily suffer the physiological processes of aging. However, an explicit mechanism of how aging affects human eye sight is not well expressed. Hence, this article seeks to present a review of the age-related physiological such as Age-related Macular Degeneration processes that affects human eyes sight. A 2-year comparison showed that the drugs Avastin (Bevacizumab) and Lucentis (Ranibizumab) lead to similar vision improvements in patients with Age-related Macular Degeneration (AMD). 

COPYRIGHT© FRONTIERSMEETINGS 2019. ALL RIGHTS RESERVED | TERMS AND CONDITIONS